tradingkey.logo

Labcorp Holdings Inc

LH
查看详细走势图
269.810USD
+1.770+0.66%
收盘 01/29, 16:00美东报价延迟15分钟
22.39B总市值
26.32市盈率 TTM

Labcorp Holdings Inc

269.810
+1.770+0.66%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.66%

5天

-0.06%

1月

+6.66%

6月

+3.09%

今年开始到现在

+7.55%

1年

+9.58%

查看详细走势图

TradingKey Labcorp Holdings Inc股票评分

单位: USD 更新时间: 2026-01-29

操作建议

Labcorp Holdings Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名3/75位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价300.09。中期看,股价处于平稳状态。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Labcorp Holdings Inc评分

相关信息

行业排名
3 / 75
全市场排名
41 / 4540
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Labcorp Holdings Inc亮点

亮点风险
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
高分红
公司属于高分红公司,最新股息支付率32.56%
估值合理
公司最新PE估值26.32,处于3年历史合理位
机构减仓
最新机构持股80.86M股,环比减少5.34%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值94.00
活跃度降低
近期活跃度降低,过去20天平均换手率-0.29

分析师目标

根据 21 位分析师
买入
评级
300.086
目标均价
+10.68%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Labcorp Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Labcorp Holdings Inc简介

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
公司代码LH
公司Labcorp Holdings Inc
CEOSchechter (Adam H)
网址https://www.labcorp.com/
KeyAI